MSB 1.04% $1.46 mesoblast limited

Ann: Remestemcel Controlled Study in Crohns & Ulcerative Colitis, page-50

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,203 Posts.
    lightbulb Created with Sketch. 5498
    This is good news.... Maybe the detail is in what the doctor said. Direct injections = 80% healing rate, which is rather high !

    They have been using these cells for a while in hospitals in Australia with success too, so I wouldn't say necessarily that the IV route failed to have an effect...


    What they may find, with direct injection they may get away with significantly less cells needed = lower cost of therapy = more competitive.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.